Viewing Study NCT04853602

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:46 AM
Ignite Modification Date: 2026-01-28 @ 5:50 PM
Study NCT ID: NCT04853602
Status: AVAILABLE
Last Update Posted: 2024-08-12
First Post: 2021-04-16
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: IFx-Hu2.0 Expanded Access Program
Sponsor: TuHURA Biosciences, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cutaneous Melanoma, Stage III View
None Cutaneous Melanoma, Stage IV View
None Merkel Cell Carcinoma View
None Cutaneous Squamous Cell Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None CM View
None MCC View
None cSCC View
None pDNA View
None plasmid DNA View
None pAc/emm55 View
None IFx-Hu.20 View
None Immunotherapy View
None Gene Therapy View
None Immunology View
None Oncology View
None Immuno-Oncology View